What is NovoCure's pre-tax income?

NovoCure (NVCR) reported pre-tax income of -$69.26M in Q1 2026.

How has NovoCure's pre-tax income changed year-over-year?

NovoCure's pre-tax income decreased by 128.6% year-over-year, from -$30.3M to -$69.26M.

What is the long-term trend for NovoCure's pre-tax income?

Over 4 years (2021 to 2025), NovoCure's pre-tax income has grown at a 27.2% compound annual growth rate (CAGR), from -$52.08M to -$136.25M.

What does pre-tax income mean?

Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

NovoCure NVCR Pre-Tax Income

Pre-Tax Income at other companies

Boston ScientificBSX

$1.16B+44.3%

MedtronicMDT

$1.83B+45.4%

Iovance Biotherapeutics, Inc.IOVA

-$79.71M+32.4%

Nuvation BioNUVB

$5.4M+110%

Vir Biotechnology, Inc.VIR

-$125.53M-3.8%

BillionToOne, Inc. BLLN

$18.51M+576%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's pre-tax income?: NovoCure (NVCR) reported pre-tax income of -$69.26M in Q1 2026.
How has NovoCure's pre-tax income changed year-over-year?: NovoCure's pre-tax income decreased by 128.6% year-over-year, from -$30.3M to -$69.26M.
What is the long-term trend for NovoCure's pre-tax income?: Over 4 years (2021 to 2025), NovoCure's pre-tax income has grown at a 27.2% compound annual growth rate (CAGR), from -$52.08M to -$136.25M.
What does pre-tax income mean?: Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.